6Hunt SA,Baker DW,Chin MH,et al.ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult:executive summary.A report of the American Heart Association Task Force on Practic Guidelines (Committee to revise the 1995 Guidelines for the evaluation and management of Heart Failure) [J].J Am Coil Cardiol, 2001, 38(7):2101-2113.
7Cowie MR, Jourdain P, Maisel A, et al.Clinical applications of B- type natriuretic peptide(BNP) [J].Eur Heart J, 2003, 24 ( 19):1710- 1718.
8Heidenreich PA,Gubens MA,Fonarow FC, et al.Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction[J]. J Am Coil Cardiol,2004, 43(6):1019-1026.
9Torre-Amione G .Immune activation in chronic heart failure[J].Am J Cadiol,2005,95 (11):3-8.
10Gong KZ, Song G, Spiers JP, et al. Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches[J]. Int J Clin Pract, 2007,61(4):611-621.
